Study: CBD Shown to Suppress Growth Pathways in Aggressive Breast Cancer Cells

OG article by Anthony Martinelli

November 7, 2025

CBD curbs triple-negative breast cancer (TNBC) growth by blocking EGFR pathways (KRAS, PI3K, AKT) and boosting FAS for apoptosis. It enhances NK immune cells, slashing TNBC survival by 50%+ versus EGF alone. This positions CBD as a potential adjunct therapy, though dosing safety and healthy cell impacts need exploration.